Avid Bioservices Inc. (CDMO)
NASDAQ: CDMO
· Real-Time Price · USD
12.49
0.00 (0.00%)
At close: Feb 04, 2025, 3:59 PM
0.00% (1D)
| Bid | n/a |
| Market Cap | 798.9M |
| Revenue (ttm) | 142.36M |
| Net Income (ttm) | -144.15M |
| EPS (ttm) | -2.41 |
| PE Ratio (ttm) | -5.182572614107884 |
| Forward PE | -113.55 |
| Analyst | Hold |
| Ask | n/a |
| Volume | 0 |
| Avg. Volume (20D) | 1,584,407 |
| Open | 12.49 |
| Previous Close | 12.49 |
| Day's Range | 12.49 - 12.49 |
| 52-Week Range | 5.90 - 12.51 |
| Beta | 1.41 |
About CDMO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CDMO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CDMO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Avid Bioservices Inc. is scheduled to release its earnings on May 2, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
Avid Biosciences shares are trading higher after t...
Unlock content with
Pro Subscription
8 months ago
Avid Bioservices shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results. Also, RBC Capital maintained an Outperform rating on the stock and raised its price target from $8 to $12.
